Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Evaluation of the COPDnet integrated care model in patients with COPD: the study protocol.

Koolen EH, van der Wees PJ, Westert GP, Dekhuijzen R, Heijdra YF, van 't Hul AJ.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 19;13:2237-2244. doi: 10.2147/COPD.S153992. eCollection 2018.

2.

The COPDnet integrated care model.

Koolen EH, van der Wees PJ, Westert GP, Dekhuijzen R, Heijdra YF, van 't Hul AJ.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 19;13:2225-2235. doi: 10.2147/COPD.S150820. eCollection 2018.

3.

Microbiological and immunological characteristics of a lethal pulmonary Aspergillus niger infection in a non-neutropenic patient.

Workum JD, de Jong SW, Gresnigt MS, Becker KL, Pickkers P, van de Veerdonk FL, Heijdra YF, Kolwijck E.

Med Mycol Case Rep. 2018 Mar 7;21:4-7. doi: 10.1016/j.mmcr.2018.03.002. eCollection 2018 Sep.

4.

Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD.

Charususin N, Gosselink R, Decramer M, Demeyer H, McConnell A, Saey D, Maltais F, Derom E, Vermeersch S, Heijdra YF, van Helvoort H, Garms L, Schneeberger T, Kenn K, Gloeckl R, Langer D.

Thorax. 2018 Oct;73(10):942-950. doi: 10.1136/thoraxjnl-2017-211417. Epub 2018 Jun 18.

PMID:
29914940
5.

Increased Platelet-Monocyte Interaction in Stable COPD in the Absence of Platelet Hyper-Reactivity.

Aleva FE, Temba G, de Mast Q, Simons SO, de Groot PG, Heijdra YF, van der Ven AJAM.

Respiration. 2018;95(1):35-43. doi: 10.1159/000480457. Epub 2017 Oct 12.

6.

The effects of signal transducer and activator of transcription three mutations on human platelets.

Aleva FE, van de Veerdonk FL, Li Y, Tunjungputri RN, Simons S, De Groot PG, Netea MM, Heijdra YF, de Mast Q, van der Ven AJAM.

Platelets. 2018 Sep;29(6):602-609. doi: 10.1080/09537104.2017.1349309. Epub 2017 Sep 29.

PMID:
28960117
7.

The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis.

Tilanus TBM, Groothuis JT, TenBroek-Pastoor JMC, Feuth TB, Heijdra YF, Slenders JPL, Doorduin J, Van Engelen BG, Kampelmacher MJ, Raaphorst J.

Respir Res. 2017 Jul 25;18(1):144. doi: 10.1186/s12931-017-0624-8.

8.

Respiratory function in facioscapulohumeral muscular dystrophy 1.

Wohlgemuth M, Horlings CGC, van der Kooi EL, Gilhuis HJ, Hendriks JCM, van der Maarel SM, van Engelen BGM, Heijdra YF, Padberg GW.

Neuromuscul Disord. 2017 Jun;27(6):526-530. doi: 10.1016/j.nmd.2017.03.008. Epub 2017 Mar 22.

PMID:
28416348
9.

Respiratory pattern in a FSHD pediatric population.

van Kernebeek CR, Seijger CGW, Goselink RJM, Heijdra YF, van Engelen BGM.

Respir Med. 2017 May;126:130-131. doi: 10.1016/j.rmed.2017.03.007. Epub 2017 Mar 7. No abstract available.

10.

[When is a venous blood gas analysis sufficient in the emergency department?]

van Exsel JA, Simons SO, Kramers C, Heijdra YF.

Ned Tijdschr Geneeskd. 2017;161:D785. Review. Dutch.

PMID:
28145212
11.

Integral Health Status-Based Cluster Analysis in Moderate-Severe COPD Patients Identifies Three Clinical Phenotypes: Relevant for Treatment As Usual and Pulmonary Rehabilitation.

Peters JB, Boer LM, Molema J, Heijdra YF, Prins JB, Vercoulen JH.

Int J Behav Med. 2017 Aug;24(4):571-583. doi: 10.1007/s12529-016-9622-3.

12.

Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.

Geerdink JX, Simons SO, Pike R, Stauss HJ, Heijdra YF, Hurst JR.

Respir Res. 2016 Oct 28;17(1):140.

13.

Respiratory constraints during activities in daily life and the impact on health status in patients with early-stage COPD: a cross-sectional study.

van Helvoort HA, Willems LM, Dekhuijzen PR, van Hees HW, Heijdra YF.

NPJ Prim Care Respir Med. 2016 Oct 13;26:16054. doi: 10.1038/npjpcrm.2016.54.

14.

Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension.

Braam EA, Quanjel MJ, Van Haren-Willems JH, Van Oosterhout MF, Vink A, Heijdra YF, Kwakkel-van Erp JM.

Sarcoidosis Vasc Diffuse Lung Dis. 2016 Aug 1;33(2):182-5.

PMID:
27537724
15.

Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis.

Aleva FE, Voets LWLM, Simons SO, de Mast Q, van der Ven AJAM, Heijdra YF.

Chest. 2017 Mar;151(3):544-554. doi: 10.1016/j.chest.2016.07.034. Epub 2016 Aug 12. Review.

PMID:
27522956
16.

Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1.

Seijger CG, Drost G, Posma JM, van Engelen BG, Heijdra YF.

PLoS One. 2016 Mar 25;11(3):e0152344. doi: 10.1371/journal.pone.0152344. eCollection 2016.

17.

Using the Lower Limit of Normal Instead of the Conventional Cutoff Values to Define Predictors of Pulmonary Function Impairment in Subjects With Chronic Heart Failure.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Respir Care. 2016 Feb;61(2):173-83. doi: 10.4187/respcare.04101. Epub 2015 Oct 20.

18.

Prevention of exacerbations in patients with COPD and vitamin D deficiency through vitamin D supplementation (PRECOVID): a study protocol.

Rafiq R, Aleva FE, Schrumpf JA, Heijdra YF, Taube C, Daniels JM, Lips P, Bet PM, Hiemstra PS, van der Ven AJ, den Heijer M, de Jongh RT.

BMC Pulm Med. 2015 Sep 23;15:106. doi: 10.1186/s12890-015-0101-4.

19.

Serial pulmonary function tests to diagnose COPD in chronic heart failure.

Minasian AG, van den Elshout FJ, Dekhuijzen PR, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Transl Respir Med. 2014 Dec;2(1):12. Epub 2014 Sep 25.

20.

Pulmonary function impairment in patients with chronic heart failure: lower limit of normal versus conventional cutoff values.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2014 Jul-Aug;43(4):311-6. doi: 10.1016/j.hrtlng.2014.03.011.

PMID:
24992882
21.

Impact of switching to new spirometric reference equations on severity staging of airflow obstruction in COPD: a crosssectional observational study in primary care.

Sluga R, Smeele IJ, Lucas AE, Thoonen BP, Grootens-Stekelenburg JG, Heijdra YF, Schermer TR.

Prim Care Respir J. 2014 Mar;23(1):85-91. doi: 10.4104/pcrj.2014.00006.

22.

Non-resolving pneumonia in patient with obsessive--compulsive disorder.

Simons SO, Braam EA, de Boer RC, Looijen-Salamon M, Heijdra YF.

Thorax. 2014 Feb;69(2):193. doi: 10.1136/thoraxjnl-2013-203759. Epub 2013 Nov 1. No abstract available.

PMID:
24186920
23.

Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.

Ramlal SK, Visser FJ, Hop WC, Dekhuijzen PN, Heijdra YF.

Pulm Pharmacol Ther. 2014 Aug;28(2):158-64. doi: 10.1016/j.pupt.2013.09.002. Epub 2013 Sep 25.

PMID:
24076367
24.

Reply to letter to the Editor.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 Sep-Oct;42(5):388-9. doi: 10.1016/j.hrtlng.2013.07.003. No abstract available.

PMID:
23998386
25.

COPD in chronic heart failure: less common than previously thought?

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 Sep-Oct;42(5):365-71. doi: 10.1016/j.hrtlng.2013.07.002.

26.

Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis.

Barrera P, Simons SO, Luijk B, Wessels MJ, Heijdra YF.

Ann Am Thorac Soc. 2013 Aug;10(4):408-9. doi: 10.1513/AnnalsATS.201212-125OC. No abstract available.

PMID:
23952870
27.

[Medicinal intervention for COPD; even in patients with mild or moderate COPD?].

Dekhuijzen PN, van Helvoort HA, Willems LM, Heijdra YF.

Ned Tijdschr Geneeskd. 2013;157(26):A5399. Review. Dutch.

PMID:
23835231
28.

The effect of bronchodilators administered via aerochamber or a nebulizer on inspiratory lung function parameters.

Ramlal SK, Visser FJ, Hop WC, Dekhuijzen PN, Heijdra YF.

Respir Med. 2013 Sep;107(9):1393-9. doi: 10.1016/j.rmed.2013.05.008. Epub 2013 Jun 12.

29.

Reply to letter to the Editor.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 May-Jun;42(3):229-30. doi: 10.1016/j.hrtlng.2013.03.001. Epub 2013 Mar 22. No abstract available.

PMID:
23522807
30.

Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1.

Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Vercoulen JH, Heijdra YF.

Respir Med. 2013 Jun;107(6):834-40. doi: 10.1016/j.rmed.2013.02.017. Epub 2013 Mar 17.

31.

An autonomous mobile system for the management of COPD.

van der Heijden M, Lucas PJ, Lijnse B, Heijdra YF, Schermer TR.

J Biomed Inform. 2013 Jun;46(3):458-69. doi: 10.1016/j.jbi.2013.03.003. Epub 2013 Mar 15.

32.

Bronchodilator responsiveness in patients with chronic heart failure.

Minasian AG, van den Elshout FJ, Dekhuijzen PN, Vos PJ, Willems FF, van den Bergh PJ, Heijdra YF.

Heart Lung. 2013 May-Jun;42(3):208-14. doi: 10.1016/j.hrtlng.2012.11.007. Epub 2012 Dec 27.

PMID:
23273658
33.

Diagnostic accuracy of metronome-paced tachypnea to detect dynamic hyperinflation.

Lahaije AJ, Willems LM, van Hees HW, Dekhuijzen PN, van Helvoort HA, Heijdra YF.

Clin Physiol Funct Imaging. 2013 Jan;33(1):62-9. doi: 10.1111/j.1475-097X.2012.01164.x. Epub 2012 Sep 2.

PMID:
23216767
34.

[Working with the Dutch Standard of Care for COPD: using the 'Nijmegen Clinical Screening Instrument' as an aid].

Vercoulen JH, Bischoff EW, Heijdra YF.

Ned Tijdschr Geneeskd. 2012;156(45):A4919. Dutch.

PMID:
23134747
35.

Non-invasive ventilation abolishes the IL-6 response to exercise in muscle-wasted COPD patients: a pilot study.

Hannink JD, van Hees HW, Dekhuijzen PN, van Helvoort HA, Heijdra YF.

Scand J Med Sci Sports. 2014 Feb;24(1):136-43. doi: 10.1111/j.1600-0838.2012.01484.x. Epub 2012 Jun 19.

PMID:
22712527
36.

COPD Anno 2011: emphasis on bronch(iol)odilation.

Lahaije AJ, Heijdra YF, Willems LM, van Helvoort HA, Dekhuijzen PN.

J Aerosol Med Pulm Drug Deliv. 2012 Jun;25(3):148-53. doi: 10.1089/jamp.2011.0922. Review.

PMID:
22686624
37.

Manual vs. automated analysis of polysomnographic recordings in patients with chronic obstructive pulmonary disease.

Stege G, Vos PJ, Dekhuijzen PN, Hilkens PH, van de Ven MJ, Heijdra YF, van den Elshout FJ.

Sleep Breath. 2013 May;17(2):533-9. doi: 10.1007/s11325-012-0714-2. Epub 2012 May 10.

PMID:
22573057
38.

The relationship between inspiratory lung function parameters and airway hyper-responsiveness in subjects with mild to moderate COPD.

Ramlal SK, Visser FJ, Hop WC, Staffhorst B, Dekhuijzen PN, Heijdra YF.

BMC Res Notes. 2012 Apr 30;5:209. doi: 10.1186/1756-0500-5-209.

39.

Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects.

Akkermans RP, Berrevoets MA, Smeele IJ, Lucas AE, Thoonen BP, Grootens-Stekelenburg JG, Heijdra YF, van Weel C, Schermer TR.

BMC Pulm Med. 2012 Mar 22;12:12. doi: 10.1186/1471-2466-12-12.

40.

Nature and frequency of respiratory involvement in chronic progressive external ophthalmoplegia.

Smits BW, Heijdra YF, Cuppen FW, van Engelen BG.

J Neurol. 2011 Nov;258(11):2020-5. doi: 10.1007/s00415-011-6060-7. Epub 2011 May 1.

41.

Relapse after hospital admission for COPD: are routine outpatient follow-up visits the way to go?

Schermer TR, Lucas PJ, Heijdra YF.

Arch Intern Med. 2011 Apr 25;171(8):789-90; reply 790. doi: 10.1001/archinternmed.2011.145. No abstract available.

PMID:
21518953
42.

Exercises commonly used in rehabilitation of patients with chronic obstructive pulmonary disease: cardiopulmonary responses and effect over time.

van Helvoort HA, de Boer RC, van de Broek L, Dekhuijzen R, Heijdra YF.

Arch Phys Med Rehabil. 2011 Jan;92(1):111-7. doi: 10.1016/j.apmr.2010.08.012. Epub 2010 Nov 18.

PMID:
21092932
43.

Similar dynamic hyperinflation during arm and leg exercise at similar ventilation in chronic obstructive pulmonary disease.

Hannink JD, Van Helvoort HA, Dekhuijzen PN, Heijdra YF.

Med Sci Sports Exerc. 2011 Jun;43(6):996-1001. doi: 10.1249/MSS.0b013e318205e2be.

PMID:
21085035
44.

Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status.

Peters JB, Heijdra YF, Daudey L, Boer LM, Molema J, Dekhuijzen PN, Schermer TR, Vercoulen JH.

Patient Educ Couns. 2011 Nov;85(2):281-5. doi: 10.1016/j.pec.2010.08.021. Epub 2010 Sep 29.

PMID:
20884162
45.

Health status in COPD cannot be measured by the St George's Respiratory Questionnaire alone: an evaluation of the underlying concepts of this questionnaire.

Daudey L, Peters JB, Molema J, Dekhuijzen PN, Prins JB, Heijdra YF, Vercoulen JH.

Respir Res. 2010 Jul 22;11:98. doi: 10.1186/1465-9921-11-98.

46.

Pursed-lips breathing improves inspiratory capacity in chronic obstructive pulmonary disease.

Visser FJ, Ramlal S, Dekhuijzen PN, Heijdra YF.

Respiration. 2011;81(5):372-8. doi: 10.1159/000319036. Epub 2010 Jul 17.

47.

Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD.

Ramlal SK, Visser FJ, Hop WC, Dekhuijzen PN, Heijdra YF.

Respir Physiol Neurobiol. 2010 Aug 31;173(1):58-63. doi: 10.1016/j.resp.2010.06.007. Epub 2010 Jun 18.

PMID:
20601207
48.

Heart failure and COPD: partners in crime?

Hannink JD, van Helvoort HA, Dekhuijzen PN, Heijdra YF.

Respirology. 2010 Aug;15(6):895-901. doi: 10.1111/j.1440-1843.2010.01776.x. Epub 2010 Jun 4. Review.

PMID:
20546188
49.

Random variation of inspiratory lung function parameters in patients with COPD: a diagnostic accuracy study.

Visser FJ, Ramlal S, Pelzer B, Dekhuijzen PN, Heijdra YF.

BMC Pulm Med. 2010 May 14;10:28. doi: 10.1186/1471-2466-10-28.

50.

Physiologic limitations during daily life activities in COPD patients.

Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Heijdra YF.

Respir Med. 2010 Aug;104(8):1152-9. doi: 10.1016/j.rmed.2010.02.011. Epub 2010 Mar 25.

Supplemental Content

Loading ...
Support Center